Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.verified

IOVA

Price:

$7.46

Market Cap:

$2.27B

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center;...[Read more]

Industry

Biotechnology

IPO Date

2010-10-15

Stock Exchange

NASDAQ

Ticker

IOVA

The Current Ratio as of December 2024 (TTM) for Iovance Biotherapeutics, Inc. (IOVA) is 4.22

According to Iovance Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.22. This represents a change of 0.57% compared to the average of 4.20 of the last 4 quarters.

Iovance Biotherapeutics, Inc. (IOVA) Historical Current Ratio (quarterly & annually)

How has IOVA Current Ratio performed in the past?

The mean historical Current Ratio of Iovance Biotherapeutics, Inc. over the last ten years is 20.63. The current 4.22 Current Ratio has changed 1.95% with respect to the historical average. Over the past ten years (40 quarters), IOVA's Current Ratio was at its highest in in the December 2015 quarter at 63.79. The Current Ratio was at its lowest in in the December 2023 quarter at 2.79.

Quarterly (TTM)
Annual

Average

20.63

Median

13.34

Minimum

2.79

Maximum

63.79

Iovance Biotherapeutics, Inc. (IOVA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Iovance Biotherapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 209.56%

Maximum Annual Current Ratio = 63.79

Minimum Annual Increase = -75.78%

Minimum Annual Current Ratio = 2.79

Quarterly (TTM)
Annual
YearCurrent RatioChange
20232.79-45.89%
20225.16-9.43%
20215.69-50.88%
202011.5944.97%
20198.00-75.78%
201833.02118.77%
201715.09-55.77%
201634.12-46.51%
201563.79135.69%
201427.06209.56%

Iovance Biotherapeutics, Inc. (IOVA) Average Current Ratio

How has IOVA Current Ratio performed in the past?

The current Current Ratio of Iovance Biotherapeutics, Inc. (IOVA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.55

5-year avg

6.65

10-year avg

20.63

Iovance Biotherapeutics, Inc. (IOVA) Current Ratio vs. Peers

How is IOVA’s Current Ratio compared to its peers?

Iovance Biotherapeutics, Inc.’s Current Ratio is greater than PTC Therapeutics, Inc. (2.10), less than Krystal Biotech, Inc. (7.97), greater than Sarepta Therapeutics, Inc. (3.84), less than Madrigal Pharmaceuticals, Inc. (5.98), less than CureVac N.V. (0), less than Apellis Pharmaceuticals, Inc. (6.20), less than Mirati Therapeutics, Inc. (4.36), less than CohBar, Inc. (7.54), less than Rain Therapeutics Inc. (15.69), less than Ocean Biomedical, Inc. (5.58), greater than Hepion Pharmaceuticals, Inc. (0.07), greater than null (1.30),

Build a custom stock screener for Iovance Biotherapeutics, Inc. (IOVA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Iovance Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Iovance Biotherapeutics, Inc. (IOVA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Iovance Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Iovance Biotherapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Iovance Biotherapeutics, Inc. (IOVA)?

What is the highest Current Ratio for Iovance Biotherapeutics, Inc. (IOVA)?

What is the 3-year average Current Ratio for Iovance Biotherapeutics, Inc. (IOVA)?

What is the 5-year average Current Ratio for Iovance Biotherapeutics, Inc. (IOVA)?

How does the current Current Ratio for Iovance Biotherapeutics, Inc. (IOVA) compare to its historical average?